Cancer

May 3, 2018

New breast health clinic in Cool Springs makes debut

Patients at high risk for developing breast cancer can now be seen by a team of breast health experts in Cool Springs. The VU Breast Health Cool Springs clinic, located at 324 Cool Springs Blvd., Suite B, Franklin, provides a range of medical services for high-risk individuals.

By VUMC News and Communications
April 23, 2018

Toxin floats on lipid rafts

The bacterium H. pylori is a leading cause of stomach cancer, and Vanderbilt researchers are studying how one of its toxins gets into cells.

By Leigh MacMillan
April 19, 2018

Ingram sees recent cancer diagnosis as second chance

“When it’s you, it’s a whole different feeling,” Orrin Ingram said, gazing at logs burning in the fireplace.

By Tom Wilemon
April 12, 2018

Agreement renewal bolsters liver tumor research

Sirtex Medical Ltd. has renewed a grant award to Dan Brown, MD, professor of Radiology and Radiological Sciences and chief of Interventional Oncology, and his Vanderbilt Health colleagues, for a research program designed to treat patients with liver tumors that cannot be addressed with surgery.

By VUMC News and Communications
April 12, 2018

Entertainers’ support strengthens VICC melanoma research efforts

Henry Paul and Dave Robbins, members of country music group BlackHawk, as well as southern rock band The Outlaws, recently donated $40,000 to Vanderbilt-Ingram Cancer Center (VICC) in support of melanoma research. Since 2006, the band members have generated more than $100,000 for VICC.

By VUMC News and Communications
April 11, 2018

“Idling” cancer cells may return

Vanderbilt investigators have discovered that cancer treatment induces an “idling” state for cells, which could promote resistance to treatment.

By Bill Snyder
March 29, 2018

Design competition aims to assist laryngectomy patients

The first annual LaryHacks, a competition to design innovative devices, apps or methods to assist laryngectomy patients who have had their voice boxes removed, has been set for Thursday, April 12, 5 to 8 p.m., in the Wond’ry, 2414 Highland Ave. in the Vanderbilt University Engineering and Science building.
By VUMC News and Communications
March 14, 2018

Boehringer Ingelheim and Vanderbilt University expand partnership to develop novel treatment approaches for cancer

New agreement will pursue therapies targeting MCL1 (myeloid cell leukemia 1), which is highly prevalent in many difficult-to-treat cancers.
By Bill Snyder
March 8, 2018

Lovly earns scholarship grant for lung cancer research

Christine Lovly, MD, PhD, assistant professor of Medicine at Vanderbilt, has received a $200,000 grant to support promising new research on lung cancer.
By VUMC News and Communications
February 8, 2018

Study seeks to boost breast tumor immune response

Immunotherapy, which harnesses the power of the immune system, is one of the most promising forms of cancer therapy and has been shown to work well against some types of cancer.
By VUMC News and Communications
January 11, 2018

Macara named ‘Pink Tie Guy’ for Komen breast cancer research

Ian Macara, PhD, Louise B. McGavock Professor and Chair of Cell and Developmental Biology and co-leader of the Signal Transduction and Chemical Biology Research Program at Vanderbilt-Ingram Cancer Center (VICC), has been named one of the Pink Tie Guys for the Susan G. Komen Central Tennessee organization.
By VUMC News and Communications
January 11, 2018

Lung screening program continues to grow

Vanderbilt University Medical Center’s (VUMC) Lung Screening Program for patients at high risk for cancer recently reached a milestone, enrolling more than 700 patients and performing more than 1,000 CT screening examinations.
By VUMC News and Communications
December 7, 2017

Searching out pancreatic cancer risk

Vanderbilt researchers have identified a biomarker that could be used to predict pancreatic cancer risk.
By Paul Govern